Navigation Links
Optimer Reports First Quarter 2013 Financial Results
Date:5/9/2013

nd use of DIFICID, the implementation and success of DIFICID growth initiatives and entry into new markets, whether or not healthcare professionals will prescribe DIFICID, the extent to which DIFICID receives reimbursement coverage from healthcare payors and government agencies, the extent to which DIFICID will be accepted on additional hospital formularies and the timing of hospital formulary decisions, Optimer's ability to successfully coordinate commercialization efforts with Cubist under its co-promotion agreement, whether Optimer will be able to realize expected benefits under its co-promotion agreement with Cubist and its collaboration agreements with other partners, the possibility of alternative means of preventing or treating CDAD impacting adoption and sales of DIFICID, Optimer's ability, through its third-party manufacturers and logistics providers, to maintain a sufficient supply of DIFICID to meet demand, the effects of changes in Optimer's management, the outcome of Optimer's review of strategic alternatives including a possible sale of the Company, the potential for lawsuits and enforcement proceedings related to the previously disclosed investigations by U.S. authorities and other risks detailed in Optimer's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this release, and Optimer undertakes no obligation to update or revise these statements, except as may be required by law.

Contacts
Optimer Pharmaceuticals, Inc.
David Walsey , VP of Investor Relations and Corporate Communications
(858) 964-3418

Canale Communications
Jason I. Spark , Senior Vice President
(619) 849-6005

 

 Optimer Pharmaceuticals, Inc.Consolidated Statements of Operations(unaudited) Three Months Ended  March 31, 20132012Revenues:Product, net

$   16,813,536$   14,380,541Cont
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
2. Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
3. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
4. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
5. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
6. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
7. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
8. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
9. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
10. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
11. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the ... company, today announced financial results for its first quarter ... three months ended December 31, 2014, revenue was $1,336,685. ... was $229,820 or $0.02 per share.  ... "I am very pleased with the significant progress we ...
(Date:2/27/2015)... , Feb. 27, 2015  Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology, ... and Chief Executive Officer, will present live at ... invite you to join us for this Company ... updates on our commercial launch of the exVive3D ...
(Date:2/27/2015)... 27, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today announced ... Conference on Tuesday, March 10, 2015. Rob Kill ... Chief Financial Officer, will present at 4:00 p.m. Pacific ... the conference at the Ritz Carlton in ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Uroplasty to Participate in the 27th Annual ROTH Conference 2
... international study indicates that anti-inflammatory drugs may become a ... (CHD), the leading global cause of death. In investigating ... disease, the researchers used the Cardiochip, a gene analysis ... in the Center for Applied Genomics at The Children,s ...
... Pharma Group today announced that William (Bill) D. Humphries ... Merz Inc., effective March 15, 2012.  In his new ... Dermatology global business unit and will oversee strategic direction ... LLC, Merz Aesthetics, Inc. and Merz Pharma Canada, Ltd.  ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer 2
(Date:2/28/2015)... In a recent episode of SCI ... Change Athlete Development Services and Consultancy talks with ... athlete development and player engagement during and after their ... athletes face and how off-field activities are a critical ... involved in athlete development issues while in graduate school ...
(Date:2/28/2015)... March—also known as National Brain Injury ... and others that suspected head injuries, especially concussions, ... , Concussions are a form of traumatic brain ... There are 1.6-3.8 million sports-related concussions per year. ... is a brain injury. Many athletes suffer knee ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 For those ... in person, the Mesothelioma Applied Research Foundation ... on Tuesday, March 3, starting at 9:30 AM. , ... no registration. The broadcast can be accessed through any ... http://www.curemeso.org/symposium . , The Symposium is a unique event ...
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
(Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2
... Institute of Medical Sciences (AIIMS) here died Saturday of dengue ... control spread of the deadly fever in the campus. ... AIIMS after he had tested positive for dengue Thursday. His ... brain haemorrhage. ,"Kiran, a native of Hyderabad and ...
... A report has found that prices of 200 brand name drugs ... during the 12 month period ending // mid June 2006, against ... and reported in their Rx Watchdog Report released on Tuesday. It ... drugs remain the same. ,Heading the list of drugs ...
... by physicians experienced with the technique//, and pain reduction ... multi-center cohort study. ,Among the 25 patients enrolled ... a 10-point visual analog scale was 7.3 at baseline, ... 24 weeks, and 0.3 at 52 weeks, according to ...
... member Tom Mayer, MD, and colleagues studied 1,200 patients ... most were using substantial amounts of opioids when they ... drugs by graduation. One year later, however, 15% were ... patient would be out of work, and doubled the ...
... School Of Medicine have shown for the first time ... muscle mass or for replacement therapy//, which results in ... to a appalling loss of brain cells. ,High ... cause hyper excitability, volatile and violent nature, and suicidal ...
... Laws that require minors to notify or get the consent ... risky sexual behavior among teens//, according to a Florida State ... Jeffrey A. Stoops Professor of Law, and Thomas Stratmann, professor ... after they looked at the rates of gonorrhea among teenage ...
Cached Medicine News:Health News:AIIMS Student Dies of Dengue Fever 2Health News:Brand Name Drug Prices Zoom 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 3Health News:Opioids Linked to Worse Outcomes After Back Injury 2Health News:Abortion Notification, Consent Laws Reduce Risky Teen Sex 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: